Inventor · disambiguated record
Eugene Gerner
Also filed as: GERNER EUGENE · GERNER EUGENE W
12 granted patents·8 pending applications·120 citations·filing 1998–2024
91Inventor score
Files withUNIV ARIZONA10CANCER PREVENTION PHARMACEUTICALS INC2ARIZONA BOARD OF REAGENTS1ARIZONA BOARD OF REGENTS ON BEHALF OF UNIV OF ARIZONA1Cancer Prevention Pharmaceuticals1
Top patents by PatentIndex Score
20 records- 0188US9937141B2Carcinoma diagnosis and treatment, based on ODC1 genotypeUNIV ARIZONA·Filed 2015·Granted Apr 10, 2018·11 cites·20 claims
- 0288US9121852B2Carcinoma diagnosis and treatment, based on ODC1 genotypeUNIV ARIZONA STATE·Filed 2012·Granted Sep 1, 2015·14 cites·33 claims
- 0387US10845366B2Predictive markers for polyamine inhibitor cancer therapiesUNIV ARIZONA·Filed 2018·Granted Nov 24, 2020·4 cites·20 claims
- 0486US10945981B2Methods for treating familial adenomatous polyposisCANCER PREVENTION PHARMACEUTICALS INC·Filed 2020·Granted Mar 16, 2021·3 cites·20 claims
- 0584US8329636B2Carcinoma diagnosis and treatment, based on ODC1 genotypeGERNER EUGENE·Filed 2010·Granted Dec 11, 2012·16 cites·33 claims
- 0681US10151756B2Predictive markers for polyamine inhibitor cancer therapiesARIZONA BOARD OF REGENTS ON BEHALF OF UNIV OF ARIZONA·Filed 2013·Granted Dec 11, 2018·5 cites·19 claims
- 0780US10655183B2Carcinoma diagnosis and treatment based on ODC1 genotypeUNIV ARIZONA·Filed 2014·Granted May 19, 2020·4 cites·15 claims
- 0880US7056897B2Inducible expression vectors and methods of use thereofUNIV ARIZONA·Filed 2002·Granted Jun 6, 2006·10 cites·23 claims
- 0976US6258845B1DFMO and sulindac combination in cancer chemopreventionUNIV CALIFORNIA·Filed 1999·Granted Jul 10, 2001·45 cites·21 claims
- 1074US2024165063A1Methods for treating neuroblastomaUNIV ARIZONA·Filed 2023·Application pending·0 cites
- 1172US7285542B2Hyperthermic inducible expression vectors for gene therapy and methods of use thereofUNIV ARIZONA·Filed 2003·Granted Oct 23, 2007·3 cites·11 claims
- 1272US2025186380A1Methods for treating familial adenomatous polyposisCancer Prevention Pharmaceuticals·Filed 2024·Application pending·0 cites
- 1363US2021378999A1Methods for treating neuroblastomaUNIV ARIZONA·Filed 2021·Application pending·0 cites
- 1459US2022040130A1Methods for treating familial adenomatous polyposisCANCER PREVENTION PHARMACEUTICALS INC·Filed 2021·Application pending·0 cites
- 1555US2019046484A1Methods for treating neuroblastomaUNIV ARIZONA·Filed 2016·Application pending·0 cites
- 1655US2019038584A1Carcinoma diagnosis and treatment, based on odc1 genotypeUNIV ARIZONA·Filed 2018·Application pending·0 cites
- 1751US7098191B2Hyperthermic inducible expression vectors for gene therapy and methods of use thereofARIZONA BOARD OF REAGENTS·Filed 2002·Granted Aug 29, 2006·0 cites·24 claims
- 1847US2002137797A1Alpha-Difluoromethylornithine (DFMO) suppresses polyamine levels in the human prostateFiled 2001·Application pending·0 cites
- 1946US6709858B1Hyperthermic inducible expression vectors for gene therapy and methods of use thereofUNIV ARIZONA·Filed 1998·Granted Mar 23, 2004·5 cites·14 claims
- 2034US2013217743A1Cancer prevention and treatment methods based on dietary polyamine contentRAJ KAVITHA P·Filed 2011·Application pending·0 cites
Identity basis: PatentsView inventor disambiguation (2025Q4-odp release). How scoring works →